Lexicon Pharmaceuticals Inc (LXRX)

NASDAQ
Currency in USD
0.690
-0.023(-2.81%)
Closed
After Hours
0.6900.000(0.00%)
LXRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.6900.720
52 wk Range
0.6203.730
Key Statistics
Edit
Prev. Close
0.713
Open
0.72
Day's Range
0.69-0.72
52 wk Range
0.62-3.73
Volume
2.39M
Average Volume (3m)
4.8M
1-Year Change
-46.92%
Book Value / Share
0.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LXRX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3.600
Upside
+421.74%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Lexicon Pharmaceuticals Inc Company Profile

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Compare LXRX to Peers and Sector

Metrics to compare
LXRX
Peers
Sector
Relationship
P/E Ratio
−1.2x−2.8x−0.6x
PEG Ratio
−0.49−0.010.00
Price/Book
1.4x1.6x2.6x
Price / LTM Sales
47.7x19.4x3.1x
Upside (Analyst Target)
180.5%348.4%53.0%
Fair Value Upside
Unlock21.5%8.0%Unlock

Analyst Ratings

4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.600

(+421.74% Upside)

Earnings

Latest Release
Nov 12, 2024
EPS / Forecast
-0.18 / -0.16
Revenue / Forecast
1.75M / 2.92M
EPS Revisions
Last 90 days

FAQ

What Is the Lexicon (LXRX) Stock Price Today?

The Lexicon stock price today is 0.69

What Stock Exchange Does Lexicon Trade On?

Lexicon is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Lexicon?

The stock symbol for Lexicon is "LXRX."

What Is the Lexicon Market Cap?

As of today, Lexicon market cap is 252.68M.

What is Lexicon Earnings Per Share?

The Lexicon EPS is -0.744.

What Is the Next Lexicon Earnings Date?

Lexicon will release its next earnings report on 11 Mar 2025.

From a Technical Analysis Perspective, Is LXRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.